An Open-Label Pilot Study of Desvenlafaxine for Opioid-Dependent Patients With Comorbid Depression
Latest Information Update: 06 Nov 2021
At a glance
- Drugs Desvenlafaxine (Primary) ; Methadone
- Indications Depression
- Focus Adverse reactions
- 07 May 2018 Results published in the International Clinical Psychopharmacology
- 15 Aug 2017 Status changed from recruiting to completed.
- 01 Sep 2016 Planned End Date changed from 1 Apr 2016 to 1 Apr 2017.